• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于药代动力学药物暴露及三维微组织阵列高分辨率成像的微生理细胞培养系统。

A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues.

作者信息

Lohasz Christian, Loretan Jacqueline, Sterker Dario, Görlach Ekkehard, Renggli Kasper, Argast Paul, Frey Olivier, Wiesmann Marion, Wartmann Markus, Rausch Martin, Hierlemann Andreas

机构信息

ETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland.

Novartis Institutes for Biomedical Research, Basel, Switzerland.

出版信息

Front Pharmacol. 2021 Dec 21;12:785851. doi: 10.3389/fphar.2021.785851. eCollection 2021.

DOI:10.3389/fphar.2021.785851
PMID:35342386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954798/
Abstract

Understanding the pharmacokinetic/pharmacodynamic (PK/PD)-relationship of a drug candidate is key to determine effective, yet safe treatment regimens for patients. However, current testing strategies are inefficient in characterizing responses to fluctuating drug concentrations during multi-day treatment cycles. Methods based on animal models are resource-intensive and require time, while traditional cell-culturing methods usually do not provide temporally-resolved information on the effects of -like drug exposure scenarios. To address this issue, we developed a microfluidic system to 1) culture arrays of three-dimensional spheroids to 2) apply specific dynamic drug exposure profiles, and to 3) analyze spheroid growth and the invoked drug effects in 3D by means of 2-photon microscopy at tissue and single-cell level. Spheroids of fluorescently-labeled T-47D breast cancer cells were monitored under perfusion-culture conditions at short time intervals over three days and exposed to either three 24 h-PK-cycles or a dose-matched constant concentration of the phosphatidylinositol 3-kinase inhibitor BYL719. While the overall efficacy of the two treatment regimens was similar, spheroids exposed to the PK profile displayed cycle-dependent oscillations between regression and regrowth. Spheroids treated with a constant BYL719 concentration regressed at a steady, albeit slower rate. At a single-cell level, the cell density in BYL719-treated spheroids oscillated in a concentration-dependent manner. Our system represents a versatile tool for in-depth preclinical characterization of PK/PD parameters, as it enables an evaluation of drug efficacy and/or toxicity under realistic exposure conditions.

摘要

了解候选药物的药代动力学/药效学(PK/PD)关系是确定对患者有效且安全的治疗方案的关键。然而,当前的测试策略在表征多日治疗周期中对波动药物浓度的反应方面效率低下。基于动物模型的方法资源密集且耗时,而传统的细胞培养方法通常无法提供类似药物暴露情况下效应的时间分辨信息。为了解决这个问题,我们开发了一种微流控系统,用于1)培养三维球体阵列,2)应用特定的动态药物暴露曲线,以及3)通过双光子显微镜在组织和单细胞水平分析球体生长和引发的药物效应。在灌注培养条件下,以短时间间隔对荧光标记的T-47D乳腺癌细胞球体进行了三天的监测,并使其暴露于三个24小时的PK周期或磷脂酰肌醇3激酶抑制剂BYL719的剂量匹配恒定浓度下。虽然两种治疗方案的总体疗效相似,但暴露于PK曲线的球体在消退和再生长之间表现出周期依赖性振荡。用恒定浓度的BYL719处理的球体以稳定但较慢的速度消退。在单细胞水平上,BYL719处理的球体中的细胞密度以浓度依赖性方式振荡。我们的系统代表了一种用于深入临床前表征PK/PD参数的通用工具,因为它能够在实际暴露条件下评估药物疗效和/或毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/f9c4b023e407/fphar-12-785851-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/814432f40a64/fphar-12-785851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/5ee57adad756/fphar-12-785851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/96d2ea71413b/fphar-12-785851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/33eb9bba61f6/fphar-12-785851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/2ac8c7738b83/fphar-12-785851-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/f9c4b023e407/fphar-12-785851-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/814432f40a64/fphar-12-785851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/5ee57adad756/fphar-12-785851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/96d2ea71413b/fphar-12-785851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/33eb9bba61f6/fphar-12-785851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/2ac8c7738b83/fphar-12-785851-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/8954798/f9c4b023e407/fphar-12-785851-g006.jpg

相似文献

1
A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues.一种用于药代动力学药物暴露及三维微组织阵列高分辨率成像的微生理细胞培养系统。
Front Pharmacol. 2021 Dec 21;12:785851. doi: 10.3389/fphar.2021.785851. eCollection 2021.
2
Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.描述使用肝微生理系统测定药物毒性、代谢和积累的可重复性。
Clin Transl Sci. 2021 May;14(3):1049-1061. doi: 10.1111/cts.12969. Epub 2021 Apr 3.
3
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response.用于评估药物药代动力学和治疗反应的肿瘤芯片微流控平台。
Commun Biol. 2021 Aug 24;4(1):1001. doi: 10.1038/s42003-021-02526-y.
4
Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids.用于方便、高效、安全的原位灌注培养 3D 类肝球体的肝芯片平台的设计与制作。
Lab Chip. 2018 Aug 21;18(17):2547-2562. doi: 10.1039/c8lc00333e.
5
3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues.3D并不够:构建用于肿瘤基质微组织的细胞诱导微环境。
Acta Biomater. 2017 Jan 1;47:1-13. doi: 10.1016/j.actbio.2016.10.007. Epub 2016 Oct 6.
6
3D bioprinted drug-resistant breast cancer spheroids for quantitative in situ evaluation of drug resistance.3D 生物打印耐药乳腺癌球体用于耐药性的定量原位评估。
Acta Biomater. 2022 Jan 15;138:228-239. doi: 10.1016/j.actbio.2021.10.031. Epub 2021 Oct 28.
7
Tubing-Free Microfluidic Microtissue Culture System Featuring Gradual, -Like Substance Exposure Profiles.具有渐进式、类似物质暴露曲线的无管微流控微组织培养系统。
Front Bioeng Biotechnol. 2019 Apr 2;7:72. doi: 10.3389/fbioe.2019.00072. eCollection 2019.
8
Systematic Analysis of Different Cell Spheroids with a Microfluidic Device Using Scanning Electrochemical Microscopy and Gene Expression Profiling.利用扫描电化学显微镜和基因表达谱对微流控装置中不同细胞球的系统分析。
Anal Chem. 2019 Apr 2;91(7):4307-4311. doi: 10.1021/acs.analchem.9b00376. Epub 2019 Mar 15.
9
Accessing 3D microtissue metabolism: Lactate and oxygen monitoring in hepatocyte spheroids.检测 3D 微组织代谢:肝细胞球体中的乳酸和氧监测。
Biosens Bioelectron. 2017 Jan 15;87:941-948. doi: 10.1016/j.bios.2016.07.094. Epub 2016 Jul 28.
10
Modeling Pharmacokinetic Profiles for Assessment of Anti-Cancer Drug on a Microfluidic System.用于在微流控系统上评估抗癌药物的药代动力学特征建模
Micromachines (Basel). 2020 May 29;11(6):551. doi: 10.3390/mi11060551.

引用本文的文献

1
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling.使用体外微流控灌注平台和计算机模拟药代动力学-药效学模型对ClpP激动剂进行剂量优化
AAPS J. 2025 Jun 13;27(4):109. doi: 10.1208/s12248-025-01088-9.
2
Sex-specific transcriptome similarity networks elucidate comorbidity relationships.性别特异性转录组相似性网络阐明了共病关系。
bioRxiv. 2025 Jan 24:2025.01.22.634077. doi: 10.1101/2025.01.22.634077.
3
Modelling patient drug exposure profiles in vitro to narrow the valley of death.

本文引用的文献

1
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.三维球体作为癌症研究的体外临床前模型
Pharmaceutics. 2020 Dec 6;12(12):1186. doi: 10.3390/pharmaceutics12121186.
2
Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies?现在是审稿人3要求进行人体器官芯片实验而非动物验证研究的时候了吗?
Adv Sci (Weinh). 2020 Oct 12;7(22):2002030. doi: 10.1002/advs.202002030. eCollection 2020 Nov.
3
Eliminating air bubble in microfluidic systems utilizing integrated in-line sloped microstructures.
体外模拟患者药物暴露曲线以缩小“死亡谷”。
Nat Rev Bioeng. 2024 Mar;2(3):196-197. doi: 10.1038/s44222-024-00160-x. Epub 2024 Feb 7.
4
A cell culture system to model pharmacokinetics using adjustable-volume perfused mixing chambers.使用可调节体积灌注混合室模拟药代动力学的细胞培养系统。
Toxicol In Vitro. 2023 Sep;91:105623. doi: 10.1016/j.tiv.2023.105623. Epub 2023 May 24.
5
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery.用于临床前药物发现的微流控芯片肝脏模型
Pharmaceutics. 2023 Apr 21;15(4):1300. doi: 10.3390/pharmaceutics15041300.
6
Apical Medium Flow Influences the Morphology and Physiology of Human Proximal Tubular Cells in a Microphysiological System.顶端中等流速在微生理系统中影响人近端肾小管细胞的形态和生理。
Bioengineering (Basel). 2022 Sep 30;9(10):516. doi: 10.3390/bioengineering9100516.
7
Circuit-Based Design of Microfluidic Drop Networks.基于电路的微流体液滴网络设计
Micromachines (Basel). 2022 Jul 16;13(7):1124. doi: 10.3390/mi13071124.
利用集成在线斜微结构消除微流控系统中的气泡。
Biomed Microdevices. 2020 Oct 22;22(4):76. doi: 10.1007/s10544-020-00529-w.
4
Predicting Metabolism-Related Drug-Drug Interactions Using a Microphysiological Multitissue System.利用微生理多组织系统预测代谢相关的药物-药物相互作用。
Adv Biosyst. 2020 Nov;4(11):e2000079. doi: 10.1002/adbi.202000079. Epub 2020 Oct 19.
5
Organ-on-a-disc: A platform technology for the centrifugal generation and culture of microphysiological 3D cell constructs amenable for automation and parallelization.器官芯片:一种用于离心生成和培养适合自动化与并行化的微生理3D细胞构建体的平台技术。
APL Bioeng. 2020 Oct 1;4(4):046101. doi: 10.1063/5.0019766. eCollection 2020 Dec.
6
Engineered tissues and strategies to overcome challenges in drug development.工程化组织和策略以克服药物开发中的挑战。
Adv Drug Deliv Rev. 2020;158:116-139. doi: 10.1016/j.addr.2020.09.012. Epub 2020 Sep 26.
7
Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device.可控的药代动力学抗癌药物浓度曲线可导致微流控装置中结肠癌细胞的生长抑制。
Lab Chip. 2020 Aug 26;20(17):3167-3178. doi: 10.1039/d0lc00419g.
8
HepaChip-MP - a twenty-four chamber microplate for a continuously perfused liver coculture model.肝芯片-MP——一种用于连续灌注肝共培养模型的24孔微孔板。
Lab Chip. 2020 Aug 11;20(16):2911-2926. doi: 10.1039/d0lc00357c.
9
Integrated Microphysiological Systems: Transferable Organ Models and Recirculating Flow.集成微生理系统:可转移的器官模型与循环流动
Adv Biosyst. 2019 May;3(5):e1900018. doi: 10.1002/adbi.201900018. Epub 2019 Apr 1.
10
Human multi-organ chip co-culture of bronchial lung culture and liver spheroids for substance exposure studies.用于物质暴露研究的支气管肺培养和肝球体的人多器官芯片共培养
Sci Rep. 2020 May 12;10(1):7865. doi: 10.1038/s41598-020-64219-6.